UBS Group AG lifted its stake in ASP Isotopes Inc. (NASDAQ:ASPI – Free Report) by 150.3% during the 4th quarter, HoldingsChannel reports. The fund owned 2,406,457 shares of the company’s stock after buying an additional 1,445,165 shares during the period. UBS Group AG’s holdings in ASP Isotopes were worth $12,875,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also bought and sold shares of the company. Quantbot Technologies LP bought a new stake in ASP Isotopes in the 3rd quarter valued at $34,000. BNP Paribas Financial Markets grew its position in ASP Isotopes by 84.9% during the second quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock worth $41,000 after buying an additional 2,548 shares in the last quarter. Close Asset Management Ltd bought a new position in ASP Isotopes during the third quarter valued at about $72,000. Legal & General Group Plc increased its stake in ASP Isotopes by 30.4% during the third quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock valued at $81,000 after acquiring an additional 1,953 shares during the period. Finally, Tower Research Capital LLC TRC lifted its position in shares of ASP Isotopes by 96.7% in the 2nd quarter. Tower Research Capital LLC TRC now owns 10,890 shares of the company’s stock worth $80,000 after acquiring an additional 5,353 shares during the period. Institutional investors own 16.80% of the company’s stock.
ASP Isotopes Stock Performance
NASDAQ:ASPI opened at $6.09 on Friday. ASP Isotopes Inc. has a 12-month low of $3.92 and a 12-month high of $14.49. The company has a quick ratio of 12.20, a current ratio of 12.23 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $766.73 million, a PE ratio of -2.85 and a beta of 3.26. The firm has a 50-day moving average price of $5.09 and a 200 day moving average price of $6.14.
Insider Buying and Selling
In related news, CFO Heather Kiessling sold 23,124 shares of the firm’s stock in a transaction that occurred on Wednesday, April 15th. The stock was sold at an average price of $5.48, for a total transaction of $126,719.52. Following the completion of the transaction, the chief financial officer owned 709,376 shares in the company, valued at $3,887,380.48. This trade represents a 3.16% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Robert Ainscow sold 25,000 shares of the business’s stock in a transaction on Friday, March 6th. The shares were sold at an average price of $4.51, for a total value of $112,750.00. Following the completion of the sale, the chief operating officer directly owned 1,512,817 shares in the company, valued at approximately $6,822,804.67. This represents a 1.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 90,704 shares of company stock worth $463,252 in the last 90 days. 14.40% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on ASPI shares. Weiss Ratings restated a “sell (d-)” rating on shares of ASP Isotopes in a research report on Friday, March 27th. Canaccord Genuity Group reiterated a “buy” rating and set a $11.00 price target on shares of ASP Isotopes in a research note on Tuesday, April 14th. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $13.00.
Get Our Latest Stock Analysis on ASP Isotopes
ASP Isotopes Company Profile
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.
Read More
- Five stocks we like better than ASP Isotopes
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Want to see what other hedge funds are holding ASPI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ASP Isotopes Inc. (NASDAQ:ASPI – Free Report).
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.
